TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling

TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling

Recent evidence has shown that the induction of ferroptosis is a new therapeutic strategy for advanced prostate cancer (PCa) when used as a monotherapy or in combination with second-generation antiandrogens. However, whether ferroptosis inducers are effective against docetaxel-resistant PCa remains...

Full description

Bibliographic Details
Main Authors: Xingkang Jiang, Shanqi Guo, Mengyao Xu, Baojie Ma, Ranlu Liu, Yong Xu, Yangyi Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
LncRNA
docetaxel
ferroptosis
prostate cancer
PCAT1
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.862015/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.862015/full

Similar Items